Why the study?
Does Angiotensin II up-regulate TIMP-1 expression via the STAT3 pathway in human senescent fibroblasts?
Does Angiotensin II up-regulate TIMP-1 expression via the STAT3 pathway in human senescent fibroblasts?
Angiotensin II up-regulates TIMP-1 expression through the STAT3 signaling pathway in human senescent fibroblasts, suggesting a potential mechanism for sclerosis in aging tissues.
Should not change clinical practice; leaves open whether the Ang II–STAT3–TIMP-1 axis drives sclerosis in human aging.
BACKGROUND: Angiotensin II (Ang II), a principal effector of renin-angiotensin system (RAS) and increased in aging tissues, can stimulate JAK/STAT pathway via the G-protein-coupled Ang II receptor type I (AT1) and induce nuclear translocation of signal transducers and activators of transcription (STAT). To further explore the role of Ang II in aging, we examined the effect of Ang II on human replicative senescent diploid fibroblast WI-38 cells. METHODS: Human senescent WI-38 cells were incubated with Ang II, receptor antagonist PD123319, valsartan, STAT3 sense plasmid, and/or STAT3 antisense plasmids. Methods were applied including electrophoretic mobility shift assay (EMSA), Western blot, transfection, and laser scanning confocal microscopy. RESULTS: It was found that cultured human senescent WI-38 cells constitutively expressed tissue inhibitor of metalloproteinase-1 (TIMP-1), and Ang II induced TIMP-1 protein expression in both time- and dose-dependent manners. Ang II induced STAT-DNA binding activity also in both time- and dose-dependent manners. And supershift assay showed that the sis-inducing factor (SIF) band contained STAT3 proteins. STAT3 antisense oligonucleotides could inhibit both Ang II-induced STAT3-DNA binding activity as well as TIMP-1 expression. CONCLUSION: Ang II could up-regulate TIMP-1 expression through activating STAT3 signal pathway in human senescent cells, indicating that Ang II-STAT3-TIMP-1 pathway may be involved in the mechanism of sclerosis in aging tissues.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: